Clinical trial · Observational
Impact of Hysterectomy on Quality of Life and Urethral Length
Impact of Hysterectomy and Supracervical Hysterectomy on Quality of Life, Urinary Incontinence and Urethral Length
NCT03757975CI-TRIAL-00043505unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To establish the impact of hysterectomy on sexual function, urethral length and quality of life
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fibroid Uterus | Uterine Corpus Leiomyoma | ALIAS | 0.90 |
| Sex Disorder | — | UNRESOLVED | — |
| Urethral Diseases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| urethral length measure | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- label
- TAH
- description
- patients before and after total abdominal hysterectomy (TAH)
- interventionNames
- Procedure: urethral length measure
- label
- TLH
- description
- patients before and after total laparoscopic hysterectomy (TLH)
- interventionNames
- Procedure: urethral length measure
- label
- TVH
- description
- patients before and after total vaginal hysterectomy (TVH)
- interventionNames
- Procedure: urethral length measure
- label
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * patients qualified to hysterectomy due to benign condition Exclusion Criteria: * serious health condition * previous vaginal operations
References
Publications (0)
Data not yet available
No reference posted for this study.